Form 8-K - Current report:
SEC Accession No. 0001437749-25-022150
Filing Date
2025-07-03
Accepted
2025-07-03 16:36:43
Documents
15
Period of Report
2025-07-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250702_8k.htm   iXBRL 8-K 29819
2 EXHIBIT 5.1 ex_836102.htm EX-5.1 13728
7 hklogo35px.jpg GRAPHIC 8086
  Complete submission text file 0001437749-25-022150.txt   205329

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250703.xsd EX-101.SCH 4112
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250703_def.xml EX-101.DEF 13903
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250703_lab.xml EX-101.LAB 18373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250703_pre.xml EX-101.PRE 13935
17 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250702_8k_htm.xml XML 5061
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 251106039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)